Dr. Avanish Saklani is a globally respected Surgical Oncologist and a pioneer in advanced colorectal, pelvic, and peritoneal cancer surgery. With decades of experience and international training, he is widely known for managing complex and ultra-complex pelvic cancers, including recurrent and previously treated cases.

He specializes in minimally invasive, laparoscopic, and robotic cancer surgeries, with a strong focus on organ-preserving and bladder-sparing techniques that aim to achieve the best oncological outcomes while improving quality of life and recovery for patients.

Dr. Avanish Saklani is a Pioneer and has played a key role in advancing Total Mesorectal Excision (TME), pelvic exenteration, and peritoneal surface malignancy management, including cytoreductive surgery with HIPEC and other multimodal treatment strategies. His expertise extends to rare and challenging conditions such as anal canal melanoma, mucinous tumors, and advanced rectal cancers.

An internationally recognized academic leader, Dr. Avanish Saklani has authored more than 360 Peer reviewed publications (Pubmed), surgical videos, and presentations in leading global journals and conferences. He is invited as a faculty speaker and trainer at prestigious international surgical forums.

Dr. Avanish Saklani holds leadership roles in surgical oncology and robotic surgery, where he continues to combine cutting-edge technology, evidence-based care, and compassionate patient management to deliver world-class cancer treatment.